Press Releases

Featured Press Releases

New Survey Finds Majority of Americans Support…

Most Americans Recognize that Biotech Is ‘Climate Tech’ A new poll from the Biotechnology Innovation Organization (BIO) shows that majorities of Americans agree that biotech plays an important role in addressing climate change and federal…

Learn more

Using March-In as a Price Control Mechanism Is a …

The White House just announced plans to use Bayh-Dole “march-in rights” to step in and license patent rights of drugs “developed with federal funding” to other manufacturers when the price of the drug is deemed too high. BIO's Chief Advocacy Officer…

Learn more

New BIO Poll Reveals Americans Strongly Support…

Today, the Biotechnology Innovation Organization released a poll that shows voters overwhelmingly support the ORPHAN Cures Act, a recently introduced bill that would incentivize rare disease drug development. The…

Learn more

New Survey Finds Majority of Americans Support Incentivizing Biotech to Address Climate Change

December 8, 2023

New BIO Poll Reveals Americans Strongly Support the Orphan Cures Act

December 7, 2023

Using March-In as a Price Control Mechanism Is a “Dangerous Precedent To Set”

December 7, 2023

Industry Leader and Globally Recognized Patient Advocate John F. Crowley Appointed to Lead BIO as President & CEO

December 5, 2023

The Biotechnology Innovation Organization (BIO) is proud to announce that industry leader and military veteran John F. Crowley will be its new President and CEO, effective March 4. He will replace Rachel King, a longtime BIO board member and…

BIO Commends USDA-APHIS Regulatory Announcements

November 21, 2023

The Department of Agriculture’s Animal and Plant Health Inspection Service recently announced exemptions from regulations under the Plant Protection Act for several categories of plants with genetic modification that could be achieved through…

BIO Statement on WHO Pandemic Accord Negotiating Draft

October 24, 2023

After the release of the World Health Organization Pandemic Accord negotiating draft, BIO's Senior Vice President of Infectious Disease & Emerging Science Policy, Phyllis Arthur, made the following remarks: “The Biotechnology Innovation…

New USITC report shows "no credible evidence" supporting a TRIPs waiver expansion

October 17, 2023

The United States International Trade Commission (USITC) today released its “COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities” report. The report aims to analyze various issues and information gaps concerning…

Indiana Governor Eric Holcomb named BIO’s Governor of the Year

October 16, 2023

Today, the Biotechnology Innovation Organization (BIO) awarded Indiana Governor Eric Holcomb with its 2023 Governor of the Year Award. Throughout his tenure, Governor Holcomb has worked to support the promise of future bioscientific innovation and…

New BIO Working Groups Give Growing Ag & Environment Biotech Sector a Public Policy Voice

September 27, 2023

Updated regulatory working groups announced today by the Biotechnology Innovation Organization (BIO) reflect the rapidly increasing diversity and impact of BIO’s Agriculture & Environment membership and ensure that all member companies’…

ORPHAN Cures Act a "welcome and bipartisan fix" to the IRA's negative impact on drug development

September 18, 2023

Representatives John Joyce, M.D. (R-PA) and Wiley Nickel (D-NC) today introduced the Optimizing Research Progress Hope And New Cures (ORPHAN Cures Act). BIO President and CEO, Rachel King, made the following remarks: "This legislation is a welcome…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.